Intravitreal injection of triamcinolone acetonide for macular edema due to retinitis pigmentosa and other retinal diseases.
Wang
Changguang
C
Moran Eye Center, Department of Ophthalmology and Visual Science, University of Utah, Salt Lake City, UT, USA.
Hu
Jianbin
J
Bernstein
Paul S
PS
Teske
Michael P
MP
Payne
Marielle
M
Yang
Zhenglin
Z
Li
Chumei
C
Adams
David
D
Baird
Jennifer H
JH
Zhang
Kang
K
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007267:Injections; D008269:Macular Edema / Q000188:drug therapy*; D012164:Retinal Diseases / Q000188:drug therapy*; D012174:Retinitis Pigmentosa / Q000150:complications* / Q000188:drug therapy*; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014822:Vitreous Body / Q000187:drug effects*
D000305:Adrenal Cortex Hormones; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014222:Triamcinolone Acetonide